ERBB2 and breast cancer: The mammary gland is an organ subject to dynamic remodeling throughout its lifetime [7], and disruption of CP in mammary glands is a hallmark of BC with mislocalization and interaction of CP proteins with varied receptors, including HER2 (human epidermal growth factor receptor 2) [8–10], leading to aggressive behavior [8–10].